MAX Chat
Shin Nippon Biomedical Laboratories, Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.43 | 72.5 | -84.24% | 12.1 | -5.55% |
| P/S |
|
2.39 | 89.6 | -97.33% |
|
|
| P/BV |
|
1.85 | 69.35 | -97.33% |
|
|
| P/FCF |
|
-9.93 | 62.17 | -115.97% |
|
|
| Ev/Ebitda |
|
8.81 | 28.83 | -69.45% |
|
|
| Ev/S |
|
2.99 | 80.92 | -96.3% |
|
|
| Ev/FCF |
|
-12.17 | 26.69 | -145.61% |
|
|
| E/P |
|
0.0857 | 0.0253 | 238.48% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
33.95 | -141.33 | -124.03% | 38.48 | -11.75% |
| ROE |
|
18.34 | 1.54 | 1088.88% |
|
|
| ROA |
|
8.28 | 0.9718 | 752.39% |
|
|
| ROIC |
|
12.66 | 8.38 | 50.96% |
|
|
| ROS |
|
20.91 | -178.64 | -111.7% |
|
|
| ROCE |
|
20.82 | -1.67 | -1345.49% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
5/10
|
2.92 | 4.49 | -35.1% | 2.26 | +29.01% |
| Nеt Debt/Ebitda |
|
1.77 | 15.09 | -88.26% |
|
|
| Debt/Ratio |
|
0.3432 | 0.1504 | 128.22% |
|
|
| Debt/Equity |
|
1.23 | 1.11 | 10.75% |
|
|
| Debt/Net Income |
|
4.73 | -1.56 | -403.99% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.38/10
|
3.75 | 1.76 | 113.43% | 2.91 | +29.04% |
| Number of years of dividend growth |
|
0 | 1.74 | -100% | ||
| DSI |
|
1 | 0.744 | 34.41% |
|
|
| Average dividend growth |
|
34 | -31.89 | -206.6% |
|
|
| Average percentage for 5 years |
|
2.91 | 16.98 | -82.88% |
|
|
| Average percentage for payments |
|
21.36 | 29.47 | -27.54% |
|
|
| Difference from average difference in sector |
|
1.99 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
114.52 | 168.81 | -32.16% | ||
| Growth impulse Ebitda in 5 years |
|
75.84 | 397.04 | -80.9% | ||
| Growth impulse Net Income in 5 years |
|
34.56 | 292.63 | -88.19% | ||
| Growth impulse FCF in 5 years |
|
-205.19 | 355.53 | -157.71% | ||
| Growth impulse EPS in 5 years |
|
34.49 | 278.21 | -87.6% |
IP Score
6.69/10
